TY - JOUR
T1 - A role for PKCζ in potentiation of the topoisomerase II activity and etoposide cytotoxicity by wortmannin
AU - Reis, Caroline
AU - Giocanti, Nicole
AU - Hennequin, Christophe
AU - Mégnin-Chanet, Frédérique
AU - Fernet, Marie
AU - Filomenko, Rodolphe
AU - Bettaieb, Ali
AU - Solary, Eric
AU - Favaudon, Vincent
PY - 2005/10/1
Y1 - 2005/10/1
N2 - Enhanced cytotoxicity of etoposide by wortmannin, an inhibitor of enzymes holding a phosphatidylinositol 3-kinase domain, was investigated in eight cell lines proficient or deficient for DNA double-strand break repair. Wortmannin stimulated the decatenating activity of topoisomerase II, promoted etoposide-induced accumulation of DNA double-strand breaks, shifted the specificity for cell killing by etoposide from the S to G1 phase of the cell cycle, and potentiated the cytotoxicity of etoposide through two mechanisms. (a) Sensitization to high, micromolar amounts of etoposide required integrity of the nonhomologous end-joining repair pathway. (b) Wortmannin dramatically increased the susceptibility to low, submicromolar amounts of etoposide in a large fraction of the cell population irrespective of the status of ATM, Ku86, and DNA-PKcs. It is shown that this process correlates depression of phosphatidylinositol 3-kinase-dependent phosphorylation of the atypical, ζ isoform of protein kinase C (PKCζ). Stable expression of a dominant-negative, kinase-dead mutant of PKCζ in a tumor cell line reproduced the hypersensitivity pattern induced by wortmannin. The results are consistent with up-regulation of the topoisomerase II activity in relation to inactivation of PKCζ and indicate that PKCζ maybe a useful target to improve the efficiency of topoisomerase II poisons at low concentration.
AB - Enhanced cytotoxicity of etoposide by wortmannin, an inhibitor of enzymes holding a phosphatidylinositol 3-kinase domain, was investigated in eight cell lines proficient or deficient for DNA double-strand break repair. Wortmannin stimulated the decatenating activity of topoisomerase II, promoted etoposide-induced accumulation of DNA double-strand breaks, shifted the specificity for cell killing by etoposide from the S to G1 phase of the cell cycle, and potentiated the cytotoxicity of etoposide through two mechanisms. (a) Sensitization to high, micromolar amounts of etoposide required integrity of the nonhomologous end-joining repair pathway. (b) Wortmannin dramatically increased the susceptibility to low, submicromolar amounts of etoposide in a large fraction of the cell population irrespective of the status of ATM, Ku86, and DNA-PKcs. It is shown that this process correlates depression of phosphatidylinositol 3-kinase-dependent phosphorylation of the atypical, ζ isoform of protein kinase C (PKCζ). Stable expression of a dominant-negative, kinase-dead mutant of PKCζ in a tumor cell line reproduced the hypersensitivity pattern induced by wortmannin. The results are consistent with up-regulation of the topoisomerase II activity in relation to inactivation of PKCζ and indicate that PKCζ maybe a useful target to improve the efficiency of topoisomerase II poisons at low concentration.
UR - http://www.scopus.com/inward/record.url?scp=27644461050&partnerID=8YFLogxK
U2 - 10.1158/1535-7163.MCT-05-0156
DO - 10.1158/1535-7163.MCT-05-0156
M3 - Article
C2 - 16227394
AN - SCOPUS:27644461050
SN - 1535-7163
VL - 4
SP - 1457
EP - 1464
JO - Molecular Cancer Therapeutics
JF - Molecular Cancer Therapeutics
IS - 10
ER -